Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 161, Issue 4, pp 529–532 | Cite as

Expression of Early Activation Marker CD69 on Peripheral Blood Lymphocytes from Pregnant Women after First Trimester Alloimmunization

  • L. V. KrechetovaEmail author
  • V. V. Vtorushina
  • M. A. Nikolaeva
  • E. L. Golubeva
  • L. V. Van’ko
  • V. A. Saribegova
  • N. K. Tetruashvili
Article

We studied the expression of an early activation marker CD69 in peripheral blood lymphocytes of pregnant women with a history of recurrent pregnancy loss after immunization with paternal lymphocytes. Spontaneous and phytohemagglutinin-stimulated expression of CD69 on the surface of T cells and NK cells isolated from the peripheral blood was analyzed. On gestation week 5-6, the number of T cells expressing CD69 spontaneously and after stimulation was significantly higher in women with miscarriage than in woman with prolonged pregnancy. However, the number of cells with CD56+ phenotype expressing CD69 did not differ in these groups. No differences were found in the number of cells of all subpopulations expressing CD69 after stimulation on gestation week 12 in woman with full-term current pregnancy and in woman with physiological pregnancy.

Key Words

recurrent abortion alloimmunization CD69 activated T lymphocytes natural killers 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Krechetova LV, Stepanova EO, Nikolaeva MA, Vtorushina VV, Golubeva EL, Khachatryan NA, Tetruashvili NK, Sukhikh GT. Time course of changes in the peripheral blood lymphocyte subpopulation composition of women with recurrent miscarriage during pregravid immunocytotherapy. Akush. Ginekol. 2015:(5):33-38. Russian.Google Scholar
  2. 2.
    Pososeeva LV, Malushkina AI, Boiko EL, Sotnikova NYu, Peretyztko LP, Fetisova IN. Rehabilitation of reproductive health in couples with recurrent pregnancy loss. Ivanovo, 2008. Russian.Google Scholar
  3. 3.
    Sidel’nikova VM, Sukhikh GT. Recurrent Miscarriage. Moscow, 2011. Russian.Google Scholar
  4. 4.
    Coulam C.B, Roussev RG. Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer. J. Assist. Reprod. Genet. 2003:20(2):58-62.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ghafourian M, Karami N, Khodadadi A, Nikbakht R. Increase of CD69, CD161 and CD94 on NK cells in women with recurrent spontaneous abortion and in vitro fertilization failure. Iran J. Immunol. 2014:11(2):84-96.PubMedGoogle Scholar
  6. 6.
    Khonina NA, Broitman EV, Shevela EY, Pasman NM, Chernykh ER. Mixed lymphocyte reaction blocking factors (MLRBf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion. Arch. Gynecol. Obstet. 2013:288(4):933-937.CrossRefPubMedGoogle Scholar
  7. 7.
    Nakashima A, Shima T, Inada K, Ito M, Saito S. The balance of the immune system between T cells and NK cells in miscarriage. Am. J. Reprod. Immunol. 2012:67(4):304-310.CrossRefPubMedGoogle Scholar
  8. 8.
    Nonaka T, Takakuwa K, Ooki I, Akashi M, Yokoo T, Kikuchi A, Tanaka K. Results of immunotherapy for patients with unexplained primary recurrent abortions–prospective non-randomized cohort study. Am. J. Reprod. Immunol. 2007:58(6):530-536.CrossRefPubMedGoogle Scholar
  9. 9.
    Quack KC, Vassiliadou N, Pudney J, Anderson DJ, Hill JA. Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion. Hum. Reprod. 2001:16(5):949-955.CrossRefPubMedGoogle Scholar
  10. 10.
    Ramhorst R, García V, Agriello E, Corigliano A, Etchepareborda E, Irigoyen M, Pasanante G, Fainboim L. Intracellular expression of CD69 in endometrial and peripheral T cells represents a useful marker in women with recurrent miscarriage: modulation after allogeneic leukocyte immunotherapy. Am. J. Reprod. Immunol. 2003:49(3):149-158.CrossRefPubMedGoogle Scholar
  11. 11.
    Ramhorst RE, Fainboim L. New actors for immunological mechanisms involved in the materno-fetal tolerance. Current Women’s Health Rev. 2005:1(1):15-20. doi:  10.2174/1573404052950294.CrossRefGoogle Scholar
  12. 12.
    Reccurent Pregnancy Loss: Causes, Controversies and Treatment. Howard JA Carp., ed. London, 2007.Google Scholar
  13. 13.
    Early Pregnancy, Farquharson RG, Stephenson MD, eds. Cambridge, 2012.Google Scholar
  14. 14.
    Vassiliadou N, Searle R.F, Bulmer JN. Elevated expression of activation molecules by decidual lymphocytes in women suffering spontaneous early pregnancy loss. Hum. Reprod. 1999:14(5):1194-1200.CrossRefPubMedGoogle Scholar
  15. 15.
    Zabińska-Popiela M, Wicherek L, Gałazka K, Dutsch-Wicherek M, Kaim I, Popiela TJ, Krzysiek J, Basta A. Comparative analysis of CD56 lymphocytes and CD69 antigen expression in endometrium during decidualization. Przegl. Lek. 2006:63(4):176-178.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • L. V. Krechetova
    • 1
    Email author
  • V. V. Vtorushina
    • 1
  • M. A. Nikolaeva
    • 1
  • E. L. Golubeva
    • 1
  • L. V. Van’ko
    • 1
  • V. A. Saribegova
    • 1
  • N. K. Tetruashvili
    • 1
  1. 1.V. I. Kulakov Research Center for Obstetrics, Gynecology, and PerinatologyMinistry of Health of the Russian FederationMoscowRussia

Personalised recommendations